AUSTIN, Texas, July 22, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. The new test is a combination of the company’s original NxTAG RPP,... Read more
Fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with adaptive immune response WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 21, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP®/DELFIA® platform,... Read more
AUSTIN, Texas, July 20, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company’s xMAP® SARS-CoV-2 Multi-Antigen IgG Assay. Clinical laboratories can now use this serology assay to identify the presence of antibodies in people who have been infected with the... Read more
Brooks Automation Announces Third Quarter Fiscal 2020 Earnings Conference Call and Webcast CHELMSFORD, Mass., July 17, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2020 third quarter earnings which ended on June 30, 2020 on Thursday, July 30, 2020 after the market closes. The Company will host a conference call and live webcast... Read more
Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more
Venlo, The Netherlands, July 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced additional information on preliminary results for the second quarter and first half of 2020, along with an outlook for continued strong growth trends in the third and fourth quarters of 2020. QIAGEN also provided initial perspectives that business trends are expected... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 13, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates growth in both reported revenue and organic revenue1 of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for PerkinElmer’s full-suite... Read more
AUSTIN, Texas, July 1, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life Science Research Partners, achieving a major milestone in the company’s strategy to extend its xMAP Technology with new functionality to facilitate new applications. Initially intended... Read more
AUSTIN, Texas, June 29, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP® SARS-CoV-2 Multi-Antigen IgG assay. The assay was developed to provide additional capacity to detect antibodies in patients who may have been exposed... Read more
Company’s latest FDA EUA solution broadens RT-PCR and serology offerings available in the U.S. WALTHAM, Mass. – June 15, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer Company, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for... Read more